Comparative analysis of antiangiogenic and immunotherapeutic regimens in the treatment of metastatic pulmonary lymphoepithelioma-like carcinoma

Abstract Background and Objective Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare histological subtype of non-small cell lung cancer for which no standard treatment protocol exists in the metastatic setting. This study aims to evaluate the efficacy and safety of antiangiogenic agents an...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Journal of Cardiothoracic Surgery
المؤلفون الرئيسيون:	Fu-Lian Qu, Yao-Hong Gao, Yan Zhang, Hong-Rui Zhang, Ya-Zhen Hong, Xiao-Jing Tie, Pei-Jie Liu
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2025-07-01
الموضوعات:	Anti-tumor angiogenesis drugs Cytotoxic drugs Epstein-Barr virus (EBV) Immune checkpoint inhibitors (ICIs) Pulmonary lymphoepithelioma-like carcinoma (PLELC)
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13019-025-03534-3